Panagora Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Hold |
83,324
| – | – | 0.01% | 548 |
|
|
2025
Q1 | $1.48M | Sell |
83,324
-97,592
| -54% | -$1.74M | 0.01% | 584 |
|
|
2024
Q4 | $5.39M | Sell |
180,916
-168,895
| -48% | -$5.03M | 0.02% | 329 |
|
|
2024
Q3 | $5.47M | Sell |
349,811
-59,983
| -15% | -$938K | 0.03% | 331 |
|
|
2024
Q2 | $7.02M | Buy |
409,794
+309,805
| +310% | +$5.31M | 0.04% | 266 |
|
|
2024
Q1 | $1.56M | Buy |
+99,989
| New | +$1.56M | 0.01% | 654 |
|
|
2023
Q3 | – | Sell |
-18,503
| Closed | -$768K | – | 1286 |
|
|
2023
Q2 | $768K | Buy |
18,503
+6,615
| +56% | +$275K | ﹤0.01% | 869 |
|
|
2023
Q1 | $715K | Sell |
11,888
-214
| -2% | -$12.9K | ﹤0.01% | 966 |
|
|
2022
Q4 | $888K | Sell |
12,102
-600
| -5% | -$44K | 0.01% | 936 |
|
|
2022
Q3 | $965K | Hold |
12,702
| – | – | 0.01% | 872 |
|
|
2022
Q2 | $883K | Hold |
12,702
| – | – | 0.01% | 928 |
|
|
2022
Q1 | $1.05M | Buy |
12,702
+9,366
| +281% | +$776K | 0.01% | 914 |
|
|
2021
Q4 | $250K | Sell |
3,336
-868
| -21% | -$65K | ﹤0.01% | 1424 |
|
|
2021
Q3 | $488K | Hold |
4,204
| – | – | ﹤0.01% | 1322 |
|
|
2021
Q2 | $933K | Sell |
4,204
-477
| -10% | -$106K | 0.01% | 1026 |
|
|
2021
Q1 | $619K | Sell |
4,681
-8,551
| -65% | -$1.13M | ﹤0.01% | 1230 |
|
|
2020
Q4 | $2.29M | Buy |
13,232
+3,288
| +33% | +$569K | 0.01% | 656 |
|
|
2020
Q3 | $1.11M | Buy |
9,944
+193
| +2% | +$21.5K | 0.01% | 871 |
|
|
2020
Q2 | $578K | Sell |
9,751
-63,309
| -87% | -$3.75M | ﹤0.01% | 1146 |
|
|
2020
Q1 | $4.92M | Sell |
73,060
-27,711
| -27% | -$1.87M | 0.03% | 352 |
|
|
2019
Q4 | $8.49M | Buy |
100,771
+93,520
| +1,290% | +$7.88M | 0.04% | 363 |
|
|
2019
Q3 | $542K | Buy |
+7,251
| New | +$542K | ﹤0.01% | 1259 |
|
|
2017
Q3 | – | Sell |
-1,830
| Closed | -$32K | – | 2444 |
|
|
2017
Q2 | $32K | Buy |
+1,830
| New | +$32K | ﹤0.01% | 2159 |
|